Skip to Main Content

Paper Details

ASCO Policy Statement on Biosimilar and Interchangeable Products in Oncology.
JCO Oncol Pract
2
2023
Author NameAffiliation
Fatima CardosoChampalimaud Clinical Center Lisbon
  • 1 - 1

Datasets

Release 1.2